Market Place
Sourcing Support
Wuxi Bio`s Contracting Business Saw Influx Of US Clients In `25
24 Mar 2026 //
FIERCE PHARMA
WuXi Biologics Named to S&P Sustainability Yearbook Again
01 Mar 2026 //
PR NEWSWIRE
Wuxi Biologics Joins Hang Seng Corporate Sustainability Index
22 Oct 2025 //
PR NEWSWIRE
Wuxi Biologics Receives 2025 Global Customer Value Leadership
20 Oct 2025 //
PR NEWSWIRE
China Pharma Projects Disrupted by Sino-US tensions
17 Jun 2025 //
REUTERS
Cirius to Present at WuXi Forum During J.P. Morgan Week
08 Jan 2025 //
PR NEWSWIRE
China`s WuXi Explores Sale Of Pharma Operations As US Restrictions
03 Oct 2024 //
REUTERS
WuXi Biologics Facilities Recertified By EMA
01 Aug 2024 //
PR NEWSWIRE
WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year
10 Jul 2024 //
PR NEWSWIRE
U.S. Biosecure Act Advances with Revised Timeline
14 May 2024 //
CONTRACT PHARMA
WuXi Biologics Ireland Site Receives Three ISO Certifications
01 Mar 2024 //
PRESS RELEASE
WuXi Biologics Recognized As ESG Top-Rated By Morningstar Sustainalytics
20 Feb 2024 //
PRESS RELEASE
Lawmakers’ explosive charges turn a global spotlight on China’s WuXi
14 Feb 2024 //
ENDPTS
WuXi Biologics Granted US Patent For WuXiBodyâ„¢ Bispecific Platform
17 Jan 2024 //
PRESS RELEASE
WuXi Biologics CEO Presents At J.P. Morgan Healthcare Conference
12 Jan 2024 //
PRESS RELEASE
WuXi Biologics Signs Research Agreement With BioNTech For Antibodies
11 Jan 2024 //
PRESS RELEASE
WuXi Bio expands US presence; FujiFilm boosts autoinjector services
11 Jan 2024 //
ENDPTS
WUXI BIOLOGICS TO PARTICIAPTE AT 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
09 Jan 2024 //
PRESS RELEASE
WuXi Biologics to Increase Manufacturing Capacity in Massachusetts
08 Jan 2024 //
PRESS RELEASE
WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange
17 Nov 2023 //
PR NEWSWIRE
WuXi XDC to funnel IPO proceeds into manufacturing expansions
07 Nov 2023 //
FIERCE PHARMA
Acasti Announces WuXi Clinical as CRO to Conduct Phase 3 Trial for GTX-104
10 Jul 2023 //
PR NEWSWIRE
WuXi plans to spin off its bioconjugation subsidiary WuXi XDC
10 Jul 2023 //
FIERCE PHARMA
Obituary – Mourning the Passing of Dr. Ning Zhao
17 May 2023 //
PRESS RELEASE
Cidara Therapeutics expands partnership with WuXi XDC
02 Feb 2023 //
PHARMACEUTICAL TECHNOLOGY
U.S. Commerce removes Wuxi Biologics from unverified list
16 Dec 2022 //
REUTERS
After a quiet spell, WuXi Bio is back with another big expansion
21 Nov 2022 //
FIERCEPHARMA
WuXi Launches an Integrated Biologics CRDMO Center in Fengxian, Shanghai
21 Nov 2022 //
PRNEWSWIRE
WuXi Vaccines Establishes New Vaccines CDMO Facility in China
15 Nov 2022 //
CONTRACTPHARMA
U.S. FDA Defers Action on Filing for AT-GAA in Late-onset Pompe Disease
28 Oct 2022 //
GLOBENEWSWIRE
WuXi Biologics Provides Corporate Updates
27 Oct 2022 //
PRNEWSWIRE
WuXi Announces GMP Release of 48,000L Drug Substance Manufacturing Facility
26 Oct 2022 //
PRNEWSWIRE
WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility
23 Oct 2022 //
PRNEWSWIRE
WuXi Biologics and Toregem Sign MOU for Development of Anti-USAG-1 Antibody
11 Oct 2022 //
PRNEWSWIRE
After $10B in market value lost, China`s WuXi removed from US unverified list
10 Oct 2022 //
ENDPTS
WuXi Biologics Co. Removed from U.S. Unverified List
10 Oct 2022 //
CONTRACTPHARMA
WuXi Biologics Co., Ltd. Removed from Unverified List
09 Oct 2022 //
PRNEWSWIRE
WuXi Biologics Topped Off the Steel on its Commercial Biomanufacturing Facility
28 Sep 2022 //
PRESS RELEASE
WuXi`s Drug Substance & Product Facilities Again Approved by U.S. FDA & EMA
19 Sep 2022 //
PRNEWSWIRE
WuXi Announces GMP Release of First North American Biomanufacturing Facility
31 Aug 2022 //
PRNEWSWIRE
WuXi Biologics Reports Strong 2022 Interim Results
17 Aug 2022 //
PRNEWSWIRE
WuXi ATU Announces Licensing Agreement with Janssen for TESSA™ Technology
11 Aug 2022 //
PRNEWSWIRE
WuXi ATU Announces Licensing Agreement with Janssen for TESSA™ Technology
11 Aug 2022 //
PRNEWSWIRE
WuXi Biologics and WuXi Vaccines Sponsor “100K in 30 Days” for Ireland Charity
29 Jul 2022 //
PRESS RELEASE
WuXi Biologics Continues Strong Business Momentum for High Growth in 2022
22 Jul 2022 //
PRESS RELEASE
WuXi Biologics serves up $1.4B expansion of research and manufacturing center
19 Jul 2022 //
ENDPTS
WuXi Vaccines Received First GMP Certificate of QC Potency Lab
12 Jul 2022 //
PRNEWSWIRE
WuXi XDC & AbTis Sign MOU for Development and Manufacturing of ADC
08 Jul 2022 //
PRESS RELEASE
WuXi Biologics launches cGMP microbial products facility in Hangzhou
07 Jul 2022 //
EUROPEANPHARMACEUTICALREVIEW
Wuxi Biologics takes step to getting off U.S. `unverified` trade list
04 Jul 2022 //
NASDAQ
WuXi Biologics Continues Strong Business Momentum for Sustainable Growth in 2022
22 Jun 2022 //
PRESS RELEASE
WuXi Biologics Launches First Commercial Drug Product Facility
06 Jun 2022 //
PRESS RELEASE
HOPE Light Shines Brightly at WuXi Biologics Ireland Site for Darkness
26 May 2022 //
PRESS RELEASE
Vir Biotech, Wuxi Biologics End COVID-19 Antibody Collaboration
24 May 2022 //
BIOSPACE
WuXi Biologics’ 2021 ESG Report Reveals Company’s Strong Commitment
28 Apr 2022 //
PRESS RELEASE
WuXi Biologics Receives Bioprocessing Excellence Award from IMAPAC
15 Apr 2022 //
PRESS RELEASE
WuXi Biologics Achieved Record Growth and Profitability in 2021
22 Mar 2022 //
PRNEWSWIRE
Wuxi STA site passes EMA drug product pre-approval inspection
03 Mar 2022 //
BIOPHARMA-REPORTER
WuXi Biologics gewinnt im fünften Jahr in Folge CMO Leadership Awards
02 Mar 2022 //
PRESS RELEASE
WuXi Biologics Wins CMO Leadership Awards in All Six Core Categories
02 Mar 2022 //
PRESS RELEASE
